| scholarly article | Q13442814 |
| P50 | author | Claudia Torino | Q87596199 |
| P2093 | author name string | Carmine Zoccali | |
| Francesca Mallamaci | |||
| Giovanni Tripepi | |||
| Rocco Tripepi | |||
| P2860 | cites work | Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. | Q50756404 |
| Con: Ambulatory blood pressure measurement in patients receiving haemodialysis: a sore arm and a waste of time? | Q53487392 | ||
| Strategies for Classifying Patients Based on Office, Home, and Ambulatory Blood Pressure Measurement | Q57085319 | ||
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial | Q57274347 | ||
| Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients | Q58950768 | ||
| Dialysis options for end-stage renal disease in older people | Q26830310 | ||
| Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data | Q30843316 | ||
| Blood pressure and mortality among hemodialysis patients | Q33672511 | ||
| Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care | Q33899530 | ||
| Premature cardiovascular disease in chronic renal failure | Q34017119 | ||
| Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study | Q34715295 | ||
| Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial | Q35031598 | ||
| Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. | Q35065439 | ||
| Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients | Q35165529 | ||
| Development and validation of a predictive mortality risk score from a European hemodialysis cohort. | Q35584842 | ||
| Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker | Q35754449 | ||
| The controversies of diagnosing and treating hypertension among hemodialysis patients | Q36105147 | ||
| A Successful Multifaceted Trial to Improve Hypertension Control in Primary Care: Why Did it Work? | Q36199397 | ||
| Pro: Ambulatory blood pressure should be used in all patients on hemodialysis | Q36363677 | ||
| Blood pressure control by home monitoring: meta-analysis of randomised trials | Q36662107 | ||
| The prevalence of symptoms in end-stage renal disease: a systematic review. | Q36697889 | ||
| Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure | Q36910379 | ||
| How should hypertension be assessed and managed in hemodialysis patients? Home BP, not dialysis unit BP, should be used for managing hypertension | Q36952545 | ||
| Symptom burden, depression, and quality of life in chronic and end-stage kidney disease | Q37211063 | ||
| Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring | Q37366671 | ||
| Home blood pressure measurements for managing hypertension in hemodialysis patients | Q37449591 | ||
| Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. | Q38296875 | ||
| The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? | Q42727588 | ||
| Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial | Q42821650 | ||
| Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial | Q44437779 | ||
| NICE hypertension guideline 2011: evidence based evolution | Q46134939 | ||
| European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring | Q46202440 | ||
| Renal provider recognition of symptoms in patients on maintenance hemodialysis. | Q48459570 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal dialysis | Q202301 |
| P304 | page(s) | 1443-1448 | |
| P577 | publication date | 2015-05-28 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Moderator's view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients | |
| P478 | volume | 30 |
| Q47790800 | Blood pressure in hemodialysis: targets? |
| Q40214521 | Chronic Fluid Overload and Mortality in ESRD. |
| Q30248239 | Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis |
| Q40877464 | Highlights of the 2015 ERA-EDTA congress: chronic kidney disease, hypertension |
| Q38740191 | Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the |
| Q93026533 | Hypertension in patients on dialysis: diagnosis, mechanisms, and management |
| Q36175268 | Rationale and study design of the prospective, longitudinal, observational cohort study "rISk strAtification in end-stage renal disease" (ISAR) study |
Search more.